Global Intranasal Vaccine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
According to our (Global Info Research) latest study, the global Intranasal Vaccine market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Vaccines administered nasally
This report is a detailed and comprehensive analysis for global Intranasal Vaccine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Intranasal Vaccine market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Intranasal Vaccine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Intranasal Vaccine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Intranasal Vaccine market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Intranasal Vaccine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Intranasal Vaccine market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sanofi, AstraZeneca, Abbott, GlaxoSmithKline and Serum Institute of India, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Intranasal Vaccine market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Intranasal Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Intranasal Vaccine, with price, sales, revenue and global market share of Intranasal Vaccine from 2018 to 2023.
Chapter 3, the Intranasal Vaccine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Intranasal Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Intranasal Vaccine market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Intranasal Vaccine.
Chapter 14 and 15, to describe Intranasal Vaccine sales channel, distributors, customers, research findings and conclusion.
Vaccines administered nasally
This report is a detailed and comprehensive analysis for global Intranasal Vaccine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Intranasal Vaccine market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Intranasal Vaccine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Intranasal Vaccine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Intranasal Vaccine market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Intranasal Vaccine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Intranasal Vaccine market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sanofi, AstraZeneca, Abbott, GlaxoSmithKline and Serum Institute of India, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Intranasal Vaccine market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Flu Vaccine
- COVID-19 Vaccines
- Hospital
- Clinic
- Sanofi
- AstraZeneca
- Abbott
- GlaxoSmithKline
- Serum Institute of India
- Bharat Biotech
- Antares Pharma
- INJEX Pharma GmbH
- BioDiem
- PharmaJet and Crossject
- Beijing Wantai Biopharmaceutical Co., Ltd.
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Intranasal Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Intranasal Vaccine, with price, sales, revenue and global market share of Intranasal Vaccine from 2018 to 2023.
Chapter 3, the Intranasal Vaccine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Intranasal Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Intranasal Vaccine market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Intranasal Vaccine.
Chapter 14 and 15, to describe Intranasal Vaccine sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Intranasal Vaccine
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Intranasal Vaccine Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Flu Vaccine
1.3.3 COVID-19 Vaccines
1.4 Market Analysis by Application
1.4.1 Overview: Global Intranasal Vaccine Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Clinic
1.5 Global Intranasal Vaccine Market Size & Forecast
1.5.1 Global Intranasal Vaccine Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Intranasal Vaccine Sales Quantity (2018-2029)
1.5.3 Global Intranasal Vaccine Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 Sanofi
2.1.1 Sanofi Details
2.1.2 Sanofi Major Business
2.1.3 Sanofi Intranasal Vaccine Product and Services
2.1.4 Sanofi Intranasal Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Sanofi Recent Developments/Updates
2.2 AstraZeneca
2.2.1 AstraZeneca Details
2.2.2 AstraZeneca Major Business
2.2.3 AstraZeneca Intranasal Vaccine Product and Services
2.2.4 AstraZeneca Intranasal Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 AstraZeneca Recent Developments/Updates
2.3 Abbott
2.3.1 Abbott Details
2.3.2 Abbott Major Business
2.3.3 Abbott Intranasal Vaccine Product and Services
2.3.4 Abbott Intranasal Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Abbott Recent Developments/Updates
2.4 GlaxoSmithKline
2.4.1 GlaxoSmithKline Details
2.4.2 GlaxoSmithKline Major Business
2.4.3 GlaxoSmithKline Intranasal Vaccine Product and Services
2.4.4 GlaxoSmithKline Intranasal Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 GlaxoSmithKline Recent Developments/Updates
2.5 Serum Institute of India
2.5.1 Serum Institute of India Details
2.5.2 Serum Institute of India Major Business
2.5.3 Serum Institute of India Intranasal Vaccine Product and Services
2.5.4 Serum Institute of India Intranasal Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Serum Institute of India Recent Developments/Updates
2.6 Bharat Biotech
2.6.1 Bharat Biotech Details
2.6.2 Bharat Biotech Major Business
2.6.3 Bharat Biotech Intranasal Vaccine Product and Services
2.6.4 Bharat Biotech Intranasal Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Bharat Biotech Recent Developments/Updates
2.7 Antares Pharma
2.7.1 Antares Pharma Details
2.7.2 Antares Pharma Major Business
2.7.3 Antares Pharma Intranasal Vaccine Product and Services
2.7.4 Antares Pharma Intranasal Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Antares Pharma Recent Developments/Updates
2.8 INJEX Pharma GmbH
2.8.1 INJEX Pharma GmbH Details
2.8.2 INJEX Pharma GmbH Major Business
2.8.3 INJEX Pharma GmbH Intranasal Vaccine Product and Services
2.8.4 INJEX Pharma GmbH Intranasal Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 INJEX Pharma GmbH Recent Developments/Updates
2.9 BioDiem
2.9.1 BioDiem Details
2.9.2 BioDiem Major Business
2.9.3 BioDiem Intranasal Vaccine Product and Services
2.9.4 BioDiem Intranasal Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 BioDiem Recent Developments/Updates
2.10 PharmaJet and Crossject
2.10.1 PharmaJet and Crossject Details
2.10.2 PharmaJet and Crossject Major Business
2.10.3 PharmaJet and Crossject Intranasal Vaccine Product and Services
2.10.4 PharmaJet and Crossject Intranasal Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 PharmaJet and Crossject Recent Developments/Updates
2.11 Beijing Wantai Biopharmaceutical Co., Ltd.
2.11.1 Beijing Wantai Biopharmaceutical Co., Ltd. Details
2.11.2 Beijing Wantai Biopharmaceutical Co., Ltd. Major Business
2.11.3 Beijing Wantai Biopharmaceutical Co., Ltd. Intranasal Vaccine Product and Services
2.11.4 Beijing Wantai Biopharmaceutical Co., Ltd. Intranasal Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Beijing Wantai Biopharmaceutical Co., Ltd. Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: INTRANASAL VACCINE BY MANUFACTURER
3.1 Global Intranasal Vaccine Sales Quantity by Manufacturer (2018-2023)
3.2 Global Intranasal Vaccine Revenue by Manufacturer (2018-2023)
3.3 Global Intranasal Vaccine Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Intranasal Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Intranasal Vaccine Manufacturer Market Share in 2022
3.4.2 Top 6 Intranasal Vaccine Manufacturer Market Share in 2022
3.5 Intranasal Vaccine Market: Overall Company Footprint Analysis
3.5.1 Intranasal Vaccine Market: Region Footprint
3.5.2 Intranasal Vaccine Market: Company Product Type Footprint
3.5.3 Intranasal Vaccine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Intranasal Vaccine Market Size by Region
4.1.1 Global Intranasal Vaccine Sales Quantity by Region (2018-2029)
4.1.2 Global Intranasal Vaccine Consumption Value by Region (2018-2029)
4.1.3 Global Intranasal Vaccine Average Price by Region (2018-2029)
4.2 North America Intranasal Vaccine Consumption Value (2018-2029)
4.3 Europe Intranasal Vaccine Consumption Value (2018-2029)
4.4 Asia-Pacific Intranasal Vaccine Consumption Value (2018-2029)
4.5 South America Intranasal Vaccine Consumption Value (2018-2029)
4.6 Middle East and Africa Intranasal Vaccine Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global Intranasal Vaccine Sales Quantity by Type (2018-2029)
5.2 Global Intranasal Vaccine Consumption Value by Type (2018-2029)
5.3 Global Intranasal Vaccine Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Intranasal Vaccine Sales Quantity by Application (2018-2029)
6.2 Global Intranasal Vaccine Consumption Value by Application (2018-2029)
6.3 Global Intranasal Vaccine Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America Intranasal Vaccine Sales Quantity by Type (2018-2029)
7.2 North America Intranasal Vaccine Sales Quantity by Application (2018-2029)
7.3 North America Intranasal Vaccine Market Size by Country
7.3.1 North America Intranasal Vaccine Sales Quantity by Country (2018-2029)
7.3.2 North America Intranasal Vaccine Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe Intranasal Vaccine Sales Quantity by Type (2018-2029)
8.2 Europe Intranasal Vaccine Sales Quantity by Application (2018-2029)
8.3 Europe Intranasal Vaccine Market Size by Country
8.3.1 Europe Intranasal Vaccine Sales Quantity by Country (2018-2029)
8.3.2 Europe Intranasal Vaccine Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific Intranasal Vaccine Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Intranasal Vaccine Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Intranasal Vaccine Market Size by Region
9.3.1 Asia-Pacific Intranasal Vaccine Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Intranasal Vaccine Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America Intranasal Vaccine Sales Quantity by Type (2018-2029)
10.2 South America Intranasal Vaccine Sales Quantity by Application (2018-2029)
10.3 South America Intranasal Vaccine Market Size by Country
10.3.1 South America Intranasal Vaccine Sales Quantity by Country (2018-2029)
10.3.2 South America Intranasal Vaccine Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Intranasal Vaccine Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Intranasal Vaccine Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Intranasal Vaccine Market Size by Country
11.3.1 Middle East & Africa Intranasal Vaccine Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Intranasal Vaccine Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 Intranasal Vaccine Market Drivers
12.2 Intranasal Vaccine Market Restraints
12.3 Intranasal Vaccine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Intranasal Vaccine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Intranasal Vaccine
13.3 Intranasal Vaccine Production Process
13.4 Intranasal Vaccine Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Intranasal Vaccine Typical Distributors
14.3 Intranasal Vaccine Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Intranasal Vaccine
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Intranasal Vaccine Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Flu Vaccine
1.3.3 COVID-19 Vaccines
1.4 Market Analysis by Application
1.4.1 Overview: Global Intranasal Vaccine Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Clinic
1.5 Global Intranasal Vaccine Market Size & Forecast
1.5.1 Global Intranasal Vaccine Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Intranasal Vaccine Sales Quantity (2018-2029)
1.5.3 Global Intranasal Vaccine Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 Sanofi
2.1.1 Sanofi Details
2.1.2 Sanofi Major Business
2.1.3 Sanofi Intranasal Vaccine Product and Services
2.1.4 Sanofi Intranasal Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Sanofi Recent Developments/Updates
2.2 AstraZeneca
2.2.1 AstraZeneca Details
2.2.2 AstraZeneca Major Business
2.2.3 AstraZeneca Intranasal Vaccine Product and Services
2.2.4 AstraZeneca Intranasal Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 AstraZeneca Recent Developments/Updates
2.3 Abbott
2.3.1 Abbott Details
2.3.2 Abbott Major Business
2.3.3 Abbott Intranasal Vaccine Product and Services
2.3.4 Abbott Intranasal Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Abbott Recent Developments/Updates
2.4 GlaxoSmithKline
2.4.1 GlaxoSmithKline Details
2.4.2 GlaxoSmithKline Major Business
2.4.3 GlaxoSmithKline Intranasal Vaccine Product and Services
2.4.4 GlaxoSmithKline Intranasal Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 GlaxoSmithKline Recent Developments/Updates
2.5 Serum Institute of India
2.5.1 Serum Institute of India Details
2.5.2 Serum Institute of India Major Business
2.5.3 Serum Institute of India Intranasal Vaccine Product and Services
2.5.4 Serum Institute of India Intranasal Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Serum Institute of India Recent Developments/Updates
2.6 Bharat Biotech
2.6.1 Bharat Biotech Details
2.6.2 Bharat Biotech Major Business
2.6.3 Bharat Biotech Intranasal Vaccine Product and Services
2.6.4 Bharat Biotech Intranasal Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Bharat Biotech Recent Developments/Updates
2.7 Antares Pharma
2.7.1 Antares Pharma Details
2.7.2 Antares Pharma Major Business
2.7.3 Antares Pharma Intranasal Vaccine Product and Services
2.7.4 Antares Pharma Intranasal Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Antares Pharma Recent Developments/Updates
2.8 INJEX Pharma GmbH
2.8.1 INJEX Pharma GmbH Details
2.8.2 INJEX Pharma GmbH Major Business
2.8.3 INJEX Pharma GmbH Intranasal Vaccine Product and Services
2.8.4 INJEX Pharma GmbH Intranasal Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 INJEX Pharma GmbH Recent Developments/Updates
2.9 BioDiem
2.9.1 BioDiem Details
2.9.2 BioDiem Major Business
2.9.3 BioDiem Intranasal Vaccine Product and Services
2.9.4 BioDiem Intranasal Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 BioDiem Recent Developments/Updates
2.10 PharmaJet and Crossject
2.10.1 PharmaJet and Crossject Details
2.10.2 PharmaJet and Crossject Major Business
2.10.3 PharmaJet and Crossject Intranasal Vaccine Product and Services
2.10.4 PharmaJet and Crossject Intranasal Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 PharmaJet and Crossject Recent Developments/Updates
2.11 Beijing Wantai Biopharmaceutical Co., Ltd.
2.11.1 Beijing Wantai Biopharmaceutical Co., Ltd. Details
2.11.2 Beijing Wantai Biopharmaceutical Co., Ltd. Major Business
2.11.3 Beijing Wantai Biopharmaceutical Co., Ltd. Intranasal Vaccine Product and Services
2.11.4 Beijing Wantai Biopharmaceutical Co., Ltd. Intranasal Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Beijing Wantai Biopharmaceutical Co., Ltd. Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: INTRANASAL VACCINE BY MANUFACTURER
3.1 Global Intranasal Vaccine Sales Quantity by Manufacturer (2018-2023)
3.2 Global Intranasal Vaccine Revenue by Manufacturer (2018-2023)
3.3 Global Intranasal Vaccine Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Intranasal Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Intranasal Vaccine Manufacturer Market Share in 2022
3.4.2 Top 6 Intranasal Vaccine Manufacturer Market Share in 2022
3.5 Intranasal Vaccine Market: Overall Company Footprint Analysis
3.5.1 Intranasal Vaccine Market: Region Footprint
3.5.2 Intranasal Vaccine Market: Company Product Type Footprint
3.5.3 Intranasal Vaccine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Intranasal Vaccine Market Size by Region
4.1.1 Global Intranasal Vaccine Sales Quantity by Region (2018-2029)
4.1.2 Global Intranasal Vaccine Consumption Value by Region (2018-2029)
4.1.3 Global Intranasal Vaccine Average Price by Region (2018-2029)
4.2 North America Intranasal Vaccine Consumption Value (2018-2029)
4.3 Europe Intranasal Vaccine Consumption Value (2018-2029)
4.4 Asia-Pacific Intranasal Vaccine Consumption Value (2018-2029)
4.5 South America Intranasal Vaccine Consumption Value (2018-2029)
4.6 Middle East and Africa Intranasal Vaccine Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global Intranasal Vaccine Sales Quantity by Type (2018-2029)
5.2 Global Intranasal Vaccine Consumption Value by Type (2018-2029)
5.3 Global Intranasal Vaccine Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Intranasal Vaccine Sales Quantity by Application (2018-2029)
6.2 Global Intranasal Vaccine Consumption Value by Application (2018-2029)
6.3 Global Intranasal Vaccine Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America Intranasal Vaccine Sales Quantity by Type (2018-2029)
7.2 North America Intranasal Vaccine Sales Quantity by Application (2018-2029)
7.3 North America Intranasal Vaccine Market Size by Country
7.3.1 North America Intranasal Vaccine Sales Quantity by Country (2018-2029)
7.3.2 North America Intranasal Vaccine Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe Intranasal Vaccine Sales Quantity by Type (2018-2029)
8.2 Europe Intranasal Vaccine Sales Quantity by Application (2018-2029)
8.3 Europe Intranasal Vaccine Market Size by Country
8.3.1 Europe Intranasal Vaccine Sales Quantity by Country (2018-2029)
8.3.2 Europe Intranasal Vaccine Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific Intranasal Vaccine Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Intranasal Vaccine Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Intranasal Vaccine Market Size by Region
9.3.1 Asia-Pacific Intranasal Vaccine Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Intranasal Vaccine Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America Intranasal Vaccine Sales Quantity by Type (2018-2029)
10.2 South America Intranasal Vaccine Sales Quantity by Application (2018-2029)
10.3 South America Intranasal Vaccine Market Size by Country
10.3.1 South America Intranasal Vaccine Sales Quantity by Country (2018-2029)
10.3.2 South America Intranasal Vaccine Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Intranasal Vaccine Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Intranasal Vaccine Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Intranasal Vaccine Market Size by Country
11.3.1 Middle East & Africa Intranasal Vaccine Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Intranasal Vaccine Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 Intranasal Vaccine Market Drivers
12.2 Intranasal Vaccine Market Restraints
12.3 Intranasal Vaccine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Intranasal Vaccine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Intranasal Vaccine
13.3 Intranasal Vaccine Production Process
13.4 Intranasal Vaccine Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Intranasal Vaccine Typical Distributors
14.3 Intranasal Vaccine Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Intranasal Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Intranasal Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Sanofi Basic Information, Manufacturing Base and Competitors
Table 4. Sanofi Major Business
Table 5. Sanofi Intranasal Vaccine Product and Services
Table 6. Sanofi Intranasal Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Sanofi Recent Developments/Updates
Table 8. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 9. AstraZeneca Major Business
Table 10. AstraZeneca Intranasal Vaccine Product and Services
Table 11. AstraZeneca Intranasal Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. AstraZeneca Recent Developments/Updates
Table 13. Abbott Basic Information, Manufacturing Base and Competitors
Table 14. Abbott Major Business
Table 15. Abbott Intranasal Vaccine Product and Services
Table 16. Abbott Intranasal Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Abbott Recent Developments/Updates
Table 18. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 19. GlaxoSmithKline Major Business
Table 20. GlaxoSmithKline Intranasal Vaccine Product and Services
Table 21. GlaxoSmithKline Intranasal Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. GlaxoSmithKline Recent Developments/Updates
Table 23. Serum Institute of India Basic Information, Manufacturing Base and Competitors
Table 24. Serum Institute of India Major Business
Table 25. Serum Institute of India Intranasal Vaccine Product and Services
Table 26. Serum Institute of India Intranasal Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Serum Institute of India Recent Developments/Updates
Table 28. Bharat Biotech Basic Information, Manufacturing Base and Competitors
Table 29. Bharat Biotech Major Business
Table 30. Bharat Biotech Intranasal Vaccine Product and Services
Table 31. Bharat Biotech Intranasal Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Bharat Biotech Recent Developments/Updates
Table 33. Antares Pharma Basic Information, Manufacturing Base and Competitors
Table 34. Antares Pharma Major Business
Table 35. Antares Pharma Intranasal Vaccine Product and Services
Table 36. Antares Pharma Intranasal Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Antares Pharma Recent Developments/Updates
Table 38. INJEX Pharma GmbH Basic Information, Manufacturing Base and Competitors
Table 39. INJEX Pharma GmbH Major Business
Table 40. INJEX Pharma GmbH Intranasal Vaccine Product and Services
Table 41. INJEX Pharma GmbH Intranasal Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. INJEX Pharma GmbH Recent Developments/Updates
Table 43. BioDiem Basic Information, Manufacturing Base and Competitors
Table 44. BioDiem Major Business
Table 45. BioDiem Intranasal Vaccine Product and Services
Table 46. BioDiem Intranasal Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. BioDiem Recent Developments/Updates
Table 48. PharmaJet and Crossject Basic Information, Manufacturing Base and Competitors
Table 49. PharmaJet and Crossject Major Business
Table 50. PharmaJet and Crossject Intranasal Vaccine Product and Services
Table 51. PharmaJet and Crossject Intranasal Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. PharmaJet and Crossject Recent Developments/Updates
Table 53. Beijing Wantai Biopharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 54. Beijing Wantai Biopharmaceutical Co., Ltd. Major Business
Table 55. Beijing Wantai Biopharmaceutical Co., Ltd. Intranasal Vaccine Product and Services
Table 56. Beijing Wantai Biopharmaceutical Co., Ltd. Intranasal Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Beijing Wantai Biopharmaceutical Co., Ltd. Recent Developments/Updates
Table 58. Global Intranasal Vaccine Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 59. Global Intranasal Vaccine Revenue by Manufacturer (2018-2023) & (USD Million)
Table 60. Global Intranasal Vaccine Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 61. Market Position of Manufacturers in Intranasal Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 62. Head Office and Intranasal Vaccine Production Site of Key Manufacturer
Table 63. Intranasal Vaccine Market: Company Product Type Footprint
Table 64. Intranasal Vaccine Market: Company Product Application Footprint
Table 65. Intranasal Vaccine New Market Entrants and Barriers to Market Entry
Table 66. Intranasal Vaccine Mergers, Acquisition, Agreements, and Collaborations
Table 67. Global Intranasal Vaccine Sales Quantity by Region (2018-2023) & (K Units)
Table 68. Global Intranasal Vaccine Sales Quantity by Region (2024-2029) & (K Units)
Table 69. Global Intranasal Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 70. Global Intranasal Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 71. Global Intranasal Vaccine Average Price by Region (2018-2023) & (US$/Unit)
Table 72. Global Intranasal Vaccine Average Price by Region (2024-2029) & (US$/Unit)
Table 73. Global Intranasal Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 74. Global Intranasal Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 75. Global Intranasal Vaccine Consumption Value by Type (2018-2023) & (USD Million)
Table 76. Global Intranasal Vaccine Consumption Value by Type (2024-2029) & (USD Million)
Table 77. Global Intranasal Vaccine Average Price by Type (2018-2023) & (US$/Unit)
Table 78. Global Intranasal Vaccine Average Price by Type (2024-2029) & (US$/Unit)
Table 79. Global Intranasal Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 80. Global Intranasal Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 81. Global Intranasal Vaccine Consumption Value by Application (2018-2023) & (USD Million)
Table 82. Global Intranasal Vaccine Consumption Value by Application (2024-2029) & (USD Million)
Table 83. Global Intranasal Vaccine Average Price by Application (2018-2023) & (US$/Unit)
Table 84. Global Intranasal Vaccine Average Price by Application (2024-2029) & (US$/Unit)
Table 85. North America Intranasal Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 86. North America Intranasal Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 87. North America Intranasal Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 88. North America Intranasal Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 89. North America Intranasal Vaccine Sales Quantity by Country (2018-2023) & (K Units)
Table 90. North America Intranasal Vaccine Sales Quantity by Country (2024-2029) & (K Units)
Table 91. North America Intranasal Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 92. North America Intranasal Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 93. Europe Intranasal Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 94. Europe Intranasal Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 95. Europe Intranasal Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 96. Europe Intranasal Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 97. Europe Intranasal Vaccine Sales Quantity by Country (2018-2023) & (K Units)
Table 98. Europe Intranasal Vaccine Sales Quantity by Country (2024-2029) & (K Units)
Table 99. Europe Intranasal Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 100. Europe Intranasal Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 101. Asia-Pacific Intranasal Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 102. Asia-Pacific Intranasal Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 103. Asia-Pacific Intranasal Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 104. Asia-Pacific Intranasal Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 105. Asia-Pacific Intranasal Vaccine Sales Quantity by Region (2018-2023) & (K Units)
Table 106. Asia-Pacific Intranasal Vaccine Sales Quantity by Region (2024-2029) & (K Units)
Table 107. Asia-Pacific Intranasal Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 108. Asia-Pacific Intranasal Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 109. South America Intranasal Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 110. South America Intranasal Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 111. South America Intranasal Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 112. South America Intranasal Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 113. South America Intranasal Vaccine Sales Quantity by Country (2018-2023) & (K Units)
Table 114. South America Intranasal Vaccine Sales Quantity by Country (2024-2029) & (K Units)
Table 115. South America Intranasal Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 116. South America Intranasal Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 117. Middle East & Africa Intranasal Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 118. Middle East & Africa Intranasal Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 119. Middle East & Africa Intranasal Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 120. Middle East & Africa Intranasal Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 121. Middle East & Africa Intranasal Vaccine Sales Quantity by Region (2018-2023) & (K Units)
Table 122. Middle East & Africa Intranasal Vaccine Sales Quantity by Region (2024-2029) & (K Units)
Table 123. Middle East & Africa Intranasal Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 124. Middle East & Africa Intranasal Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 125. Intranasal Vaccine Raw Material
Table 126. Key Manufacturers of Intranasal Vaccine Raw Materials
Table 127. Intranasal Vaccine Typical Distributors
Table 128. Intranasal Vaccine Typical Customers
Table 1. Global Intranasal Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Intranasal Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Sanofi Basic Information, Manufacturing Base and Competitors
Table 4. Sanofi Major Business
Table 5. Sanofi Intranasal Vaccine Product and Services
Table 6. Sanofi Intranasal Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Sanofi Recent Developments/Updates
Table 8. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 9. AstraZeneca Major Business
Table 10. AstraZeneca Intranasal Vaccine Product and Services
Table 11. AstraZeneca Intranasal Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. AstraZeneca Recent Developments/Updates
Table 13. Abbott Basic Information, Manufacturing Base and Competitors
Table 14. Abbott Major Business
Table 15. Abbott Intranasal Vaccine Product and Services
Table 16. Abbott Intranasal Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Abbott Recent Developments/Updates
Table 18. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 19. GlaxoSmithKline Major Business
Table 20. GlaxoSmithKline Intranasal Vaccine Product and Services
Table 21. GlaxoSmithKline Intranasal Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. GlaxoSmithKline Recent Developments/Updates
Table 23. Serum Institute of India Basic Information, Manufacturing Base and Competitors
Table 24. Serum Institute of India Major Business
Table 25. Serum Institute of India Intranasal Vaccine Product and Services
Table 26. Serum Institute of India Intranasal Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Serum Institute of India Recent Developments/Updates
Table 28. Bharat Biotech Basic Information, Manufacturing Base and Competitors
Table 29. Bharat Biotech Major Business
Table 30. Bharat Biotech Intranasal Vaccine Product and Services
Table 31. Bharat Biotech Intranasal Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Bharat Biotech Recent Developments/Updates
Table 33. Antares Pharma Basic Information, Manufacturing Base and Competitors
Table 34. Antares Pharma Major Business
Table 35. Antares Pharma Intranasal Vaccine Product and Services
Table 36. Antares Pharma Intranasal Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Antares Pharma Recent Developments/Updates
Table 38. INJEX Pharma GmbH Basic Information, Manufacturing Base and Competitors
Table 39. INJEX Pharma GmbH Major Business
Table 40. INJEX Pharma GmbH Intranasal Vaccine Product and Services
Table 41. INJEX Pharma GmbH Intranasal Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. INJEX Pharma GmbH Recent Developments/Updates
Table 43. BioDiem Basic Information, Manufacturing Base and Competitors
Table 44. BioDiem Major Business
Table 45. BioDiem Intranasal Vaccine Product and Services
Table 46. BioDiem Intranasal Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. BioDiem Recent Developments/Updates
Table 48. PharmaJet and Crossject Basic Information, Manufacturing Base and Competitors
Table 49. PharmaJet and Crossject Major Business
Table 50. PharmaJet and Crossject Intranasal Vaccine Product and Services
Table 51. PharmaJet and Crossject Intranasal Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. PharmaJet and Crossject Recent Developments/Updates
Table 53. Beijing Wantai Biopharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 54. Beijing Wantai Biopharmaceutical Co., Ltd. Major Business
Table 55. Beijing Wantai Biopharmaceutical Co., Ltd. Intranasal Vaccine Product and Services
Table 56. Beijing Wantai Biopharmaceutical Co., Ltd. Intranasal Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Beijing Wantai Biopharmaceutical Co., Ltd. Recent Developments/Updates
Table 58. Global Intranasal Vaccine Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 59. Global Intranasal Vaccine Revenue by Manufacturer (2018-2023) & (USD Million)
Table 60. Global Intranasal Vaccine Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 61. Market Position of Manufacturers in Intranasal Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 62. Head Office and Intranasal Vaccine Production Site of Key Manufacturer
Table 63. Intranasal Vaccine Market: Company Product Type Footprint
Table 64. Intranasal Vaccine Market: Company Product Application Footprint
Table 65. Intranasal Vaccine New Market Entrants and Barriers to Market Entry
Table 66. Intranasal Vaccine Mergers, Acquisition, Agreements, and Collaborations
Table 67. Global Intranasal Vaccine Sales Quantity by Region (2018-2023) & (K Units)
Table 68. Global Intranasal Vaccine Sales Quantity by Region (2024-2029) & (K Units)
Table 69. Global Intranasal Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 70. Global Intranasal Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 71. Global Intranasal Vaccine Average Price by Region (2018-2023) & (US$/Unit)
Table 72. Global Intranasal Vaccine Average Price by Region (2024-2029) & (US$/Unit)
Table 73. Global Intranasal Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 74. Global Intranasal Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 75. Global Intranasal Vaccine Consumption Value by Type (2018-2023) & (USD Million)
Table 76. Global Intranasal Vaccine Consumption Value by Type (2024-2029) & (USD Million)
Table 77. Global Intranasal Vaccine Average Price by Type (2018-2023) & (US$/Unit)
Table 78. Global Intranasal Vaccine Average Price by Type (2024-2029) & (US$/Unit)
Table 79. Global Intranasal Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 80. Global Intranasal Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 81. Global Intranasal Vaccine Consumption Value by Application (2018-2023) & (USD Million)
Table 82. Global Intranasal Vaccine Consumption Value by Application (2024-2029) & (USD Million)
Table 83. Global Intranasal Vaccine Average Price by Application (2018-2023) & (US$/Unit)
Table 84. Global Intranasal Vaccine Average Price by Application (2024-2029) & (US$/Unit)
Table 85. North America Intranasal Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 86. North America Intranasal Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 87. North America Intranasal Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 88. North America Intranasal Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 89. North America Intranasal Vaccine Sales Quantity by Country (2018-2023) & (K Units)
Table 90. North America Intranasal Vaccine Sales Quantity by Country (2024-2029) & (K Units)
Table 91. North America Intranasal Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 92. North America Intranasal Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 93. Europe Intranasal Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 94. Europe Intranasal Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 95. Europe Intranasal Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 96. Europe Intranasal Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 97. Europe Intranasal Vaccine Sales Quantity by Country (2018-2023) & (K Units)
Table 98. Europe Intranasal Vaccine Sales Quantity by Country (2024-2029) & (K Units)
Table 99. Europe Intranasal Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 100. Europe Intranasal Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 101. Asia-Pacific Intranasal Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 102. Asia-Pacific Intranasal Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 103. Asia-Pacific Intranasal Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 104. Asia-Pacific Intranasal Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 105. Asia-Pacific Intranasal Vaccine Sales Quantity by Region (2018-2023) & (K Units)
Table 106. Asia-Pacific Intranasal Vaccine Sales Quantity by Region (2024-2029) & (K Units)
Table 107. Asia-Pacific Intranasal Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 108. Asia-Pacific Intranasal Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 109. South America Intranasal Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 110. South America Intranasal Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 111. South America Intranasal Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 112. South America Intranasal Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 113. South America Intranasal Vaccine Sales Quantity by Country (2018-2023) & (K Units)
Table 114. South America Intranasal Vaccine Sales Quantity by Country (2024-2029) & (K Units)
Table 115. South America Intranasal Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 116. South America Intranasal Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 117. Middle East & Africa Intranasal Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 118. Middle East & Africa Intranasal Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 119. Middle East & Africa Intranasal Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 120. Middle East & Africa Intranasal Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 121. Middle East & Africa Intranasal Vaccine Sales Quantity by Region (2018-2023) & (K Units)
Table 122. Middle East & Africa Intranasal Vaccine Sales Quantity by Region (2024-2029) & (K Units)
Table 123. Middle East & Africa Intranasal Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 124. Middle East & Africa Intranasal Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 125. Intranasal Vaccine Raw Material
Table 126. Key Manufacturers of Intranasal Vaccine Raw Materials
Table 127. Intranasal Vaccine Typical Distributors
Table 128. Intranasal Vaccine Typical Customers
LIST OF FIGURES
Figure 1. Intranasal Vaccine Picture
Figure 2. Global Intranasal Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Intranasal Vaccine Consumption Value Market Share by Type in 2022
Figure 4. Flu Vaccine Examples
Figure 5. COVID-19 Vaccines Examples
Figure 6. Global Intranasal Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Intranasal Vaccine Consumption Value Market Share by Application in 2022
Figure 8. Hospital Examples
Figure 9. Clinic Examples
Figure 10. Global Intranasal Vaccine Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 11. Global Intranasal Vaccine Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 12. Global Intranasal Vaccine Sales Quantity (2018-2029) & (K Units)
Figure 13. Global Intranasal Vaccine Average Price (2018-2029) & (US$/Unit)
Figure 14. Global Intranasal Vaccine Sales Quantity Market Share by Manufacturer in 2022
Figure 15. Global Intranasal Vaccine Consumption Value Market Share by Manufacturer in 2022
Figure 16. Producer Shipments of Intranasal Vaccine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 17. Top 3 Intranasal Vaccine Manufacturer (Consumption Value) Market Share in 2022
Figure 18. Top 6 Intranasal Vaccine Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Global Intranasal Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 20. Global Intranasal Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 21. North America Intranasal Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 22. Europe Intranasal Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 23. Asia-Pacific Intranasal Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 24. South America Intranasal Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 25. Middle East & Africa Intranasal Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 26. Global Intranasal Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 27. Global Intranasal Vaccine Consumption Value Market Share by Type (2018-2029)
Figure 28. Global Intranasal Vaccine Average Price by Type (2018-2029) & (US$/Unit)
Figure 29. Global Intranasal Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 30. Global Intranasal Vaccine Consumption Value Market Share by Application (2018-2029)
Figure 31. Global Intranasal Vaccine Average Price by Application (2018-2029) & (US$/Unit)
Figure 32. North America Intranasal Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 33. North America Intranasal Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 34. North America Intranasal Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 35. North America Intranasal Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 36. United States Intranasal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 37. Canada Intranasal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Mexico Intranasal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Europe Intranasal Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 40. Europe Intranasal Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 41. Europe Intranasal Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 42. Europe Intranasal Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 43. Germany Intranasal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. France Intranasal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. United Kingdom Intranasal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. Russia Intranasal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Italy Intranasal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Asia-Pacific Intranasal Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 49. Asia-Pacific Intranasal Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 50. Asia-Pacific Intranasal Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 51. Asia-Pacific Intranasal Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 52. China Intranasal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Japan Intranasal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Korea Intranasal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. India Intranasal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Southeast Asia Intranasal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Australia Intranasal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. South America Intranasal Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 59. South America Intranasal Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 60. South America Intranasal Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 61. South America Intranasal Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 62. Brazil Intranasal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. Argentina Intranasal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Middle East & Africa Intranasal Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 65. Middle East & Africa Intranasal Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 66. Middle East & Africa Intranasal Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 67. Middle East & Africa Intranasal Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 68. Turkey Intranasal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 69. Egypt Intranasal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Saudi Arabia Intranasal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. South Africa Intranasal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Intranasal Vaccine Market Drivers
Figure 73. Intranasal Vaccine Market Restraints
Figure 74. Intranasal Vaccine Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Intranasal Vaccine in 2022
Figure 77. Manufacturing Process Analysis of Intranasal Vaccine
Figure 78. Intranasal Vaccine Industrial Chain
Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source
Figure 1. Intranasal Vaccine Picture
Figure 2. Global Intranasal Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Intranasal Vaccine Consumption Value Market Share by Type in 2022
Figure 4. Flu Vaccine Examples
Figure 5. COVID-19 Vaccines Examples
Figure 6. Global Intranasal Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Intranasal Vaccine Consumption Value Market Share by Application in 2022
Figure 8. Hospital Examples
Figure 9. Clinic Examples
Figure 10. Global Intranasal Vaccine Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 11. Global Intranasal Vaccine Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 12. Global Intranasal Vaccine Sales Quantity (2018-2029) & (K Units)
Figure 13. Global Intranasal Vaccine Average Price (2018-2029) & (US$/Unit)
Figure 14. Global Intranasal Vaccine Sales Quantity Market Share by Manufacturer in 2022
Figure 15. Global Intranasal Vaccine Consumption Value Market Share by Manufacturer in 2022
Figure 16. Producer Shipments of Intranasal Vaccine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 17. Top 3 Intranasal Vaccine Manufacturer (Consumption Value) Market Share in 2022
Figure 18. Top 6 Intranasal Vaccine Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Global Intranasal Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 20. Global Intranasal Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 21. North America Intranasal Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 22. Europe Intranasal Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 23. Asia-Pacific Intranasal Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 24. South America Intranasal Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 25. Middle East & Africa Intranasal Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 26. Global Intranasal Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 27. Global Intranasal Vaccine Consumption Value Market Share by Type (2018-2029)
Figure 28. Global Intranasal Vaccine Average Price by Type (2018-2029) & (US$/Unit)
Figure 29. Global Intranasal Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 30. Global Intranasal Vaccine Consumption Value Market Share by Application (2018-2029)
Figure 31. Global Intranasal Vaccine Average Price by Application (2018-2029) & (US$/Unit)
Figure 32. North America Intranasal Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 33. North America Intranasal Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 34. North America Intranasal Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 35. North America Intranasal Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 36. United States Intranasal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 37. Canada Intranasal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Mexico Intranasal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Europe Intranasal Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 40. Europe Intranasal Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 41. Europe Intranasal Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 42. Europe Intranasal Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 43. Germany Intranasal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. France Intranasal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. United Kingdom Intranasal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. Russia Intranasal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Italy Intranasal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Asia-Pacific Intranasal Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 49. Asia-Pacific Intranasal Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 50. Asia-Pacific Intranasal Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 51. Asia-Pacific Intranasal Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 52. China Intranasal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Japan Intranasal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Korea Intranasal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. India Intranasal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Southeast Asia Intranasal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Australia Intranasal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. South America Intranasal Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 59. South America Intranasal Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 60. South America Intranasal Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 61. South America Intranasal Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 62. Brazil Intranasal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. Argentina Intranasal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Middle East & Africa Intranasal Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 65. Middle East & Africa Intranasal Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 66. Middle East & Africa Intranasal Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 67. Middle East & Africa Intranasal Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 68. Turkey Intranasal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 69. Egypt Intranasal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Saudi Arabia Intranasal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. South Africa Intranasal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Intranasal Vaccine Market Drivers
Figure 73. Intranasal Vaccine Market Restraints
Figure 74. Intranasal Vaccine Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Intranasal Vaccine in 2022
Figure 77. Manufacturing Process Analysis of Intranasal Vaccine
Figure 78. Intranasal Vaccine Industrial Chain
Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source
